AAAAAA
Results: 1-25/40
Authors:
Strand, V
Citation: V. Strand, Monoclonal antibodies and other biologic therapies, LUPUS, 10(3), 2001, pp. 216-221
Authors:
Strand, V
Citation: V. Strand, New therapies in development for autoimmune diseases: their rationale for combination treatment, SPR SEM IMM, 23(1-2), 2001, pp. 43-61
Authors:
Woodworth, TG
Furst, DE
Strand, V
Kempeni, J
Fenner, H
Lau, CS
Miller, F
Day, R
Lipani, J
Brooks, P
Citation: Tg. Woodworth et al., Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: Towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies, J RHEUMATOL, 28(5), 2001, pp. 1163-1169
Authors:
Lipani, JA
Strand, V
Johnson, K
Woodworth, T
Furst, D
Singh, G
Day, R
Brooks, P
Citation: Ja. Lipani et al., A proposal for developing a large patient population cohort for longterm safety monitoring in rheumatoid arthritis, J RHEUMATOL, 28(5), 2001, pp. 1170-1173
Authors:
Welch, V
Singh, G
Strand, V
Fries, J
Boers, M
Ramey, D
Day, RO
Brooks, P
Tugwell, P
Clinch, J
Kristjansson, B
Citation: V. Welch et al., Patient based method of assessing adverse events in clinical trials in rheumatology: the revised Stanford Toxicity Index, J RHEUMATOL, 28(5), 2001, pp. 1188-1191
Authors:
Strand, V
Lassere, M
van der Heijde, D
Johnson, K
Boers, M
Citation: V. Strand et al., Recent rheumatoid arthritis clinical trials using radiographic endpoints -Updated research agenda, J RHEUMATOL, 28(4), 2001, pp. 887-889
Authors:
van der Heijde, D
Lassere, M
Edmonds, J
Kirwan, J
Strand, V
Boers, M
Citation: D. Van Der Heijde et al., Minimal clinically important difference in plain films in RA: Group discussions, conclusions, and recommendations, J RHEUMATOL, 28(4), 2001, pp. 914-917
Authors:
Beaton, DE
Bombardier, C
Katz, JN
Wright, JG
Wells, G
Boers, M
Strand, V
Shea, B
Citation: De. Beaton et al., Looking for important change/differences in studies of responsiveness, J RHEUMATOL, 28(2), 2001, pp. 400-405
Authors:
Wells, G
Beaton, D
Shea, B
Boers, M
Simon, L
Strand, V
Brooks, P
Tugwell, P
Citation: G. Wells et al., Minimal clinically important differences: Review of methods, J RHEUMATOL, 28(2), 2001, pp. 406-412
Authors:
Wells, G
Anderson, J
Beaton, D
Bellamy, N
Boers, M
Bombardier, C
Breedveld, F
Carr, A
Cranney, A
Dougados, M
Felson, D
Kirwan, J
Schiff, M
Shea, B
Simon, L
Smolen, J
Strand, V
Tugwell, P
van Riel, P
Welch, VA
Citation: G. Wells et al., Minimal clinically important difference module: Summary, recommendations, and research agenda, J RHEUMATOL, 28(2), 2001, pp. 452-454
Authors:
Lynch, N
Strand, V
Citation: N. Lynch et V. Strand, Symposium - Fordham Interdisciplinary Conference - Achieving Justice: Parents and the child welfare system - Report of the Education Working Group, FORDHAM LAW, 70(2), 2001, pp. 369-373
Authors:
Cohen, S
Cannon, GW
Schiff, M
Weaver, A
Fox, R
Olsen, N
Furst, D
Sharp, J
Moreland, L
Caldwell, J
Kaine, J
Strand, V
Citation: S. Cohen et al., Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate, ARTH RHEUM, 44(9), 2001, pp. 1984-1992
Authors:
Maetzel, A
Wong, A
Strand, V
Tugwell, P
Wells, G
Bombardier, C
Citation: A. Maetzel et al., Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs, RHEUMATOLOG, 39(9), 2000, pp. 975-981
Authors:
Molenaar, ETM
Boers, M
Brooks, PM
Simon, L
Strand, V
Tugwell, P
Citation: Etm. Molenaar et al., Recent developments for optimal end-points in rheumatoid arthritis clinical studies, DIS MANAG H, 8(2), 2000, pp. 87-97
Authors:
Strand, V
Gladman, D
Isenberg, D
Petri, M
Smolen, J
Tugwell, P
Citation: V. Strand et al., Endpoints: consensus recommendations from OMERACT IV, LUPUS, 9(5), 2000, pp. 322-327
Authors:
Svartengren, M
Strand, V
Bylin, G
Jarup, L
Pershagen, G
Citation: M. Svartengren et al., Short-term exposure to air pollution in a road tunnel enhances the asthmatic response to allergen, EUR RESP J, 15(4), 2000, pp. 716-724
Authors:
Strand, V
Citation: V. Strand, New therapies for systemic lupus erythematosus, RHEUM DIS C, 26(2), 2000, pp. 389
Authors:
Lipani, JA
Strand, V
Woodworth, T
Furst, D
Singh, G
Johnson, K
Day, R
Brooks, P
Citation: Ja. Lipani et al., A proposal for developing a large patient population cohort for longterm safety monitoring in rheumatoid arthritis, J RHEUMATOL, 27(4), 2000, pp. 827-830
Authors:
Grossman, J
van der Heijde, D
Kirwan, J
Strand, V
Sharp, J
Paulus, H
Johnson, K
Alarcon, G
Lassere, M
Shekelle, P
Anderson, J
Citation: J. Grossman et al., Alternative methods for analysis of radiographic damage in a randomized, double blind, parallel group clinical trial comparing hydroxychloroquine andsulfasalazine - Discussion, J RHEUMATOL, 27(2), 2000, pp. 538-539
Authors:
Morton, S
Paulus, H
van der Heijde, D
Shekelle, P
Strand, V
Lassere, M
Kirwan, J
Sharp, J
Sanders, M
Citation: S. Morton et al., On variability of effects for a metaanalysis of rheumatoid arthritis radiographic progression - Discussion, J RHEUMATOL, 27(2), 2000, pp. 542-543
Authors:
Leung, H
Hurley, F
Strand, V
Citation: H. Leung et al., Issues involved in a metaanalysis of rheumatoid arthritis radiographic progression. Analysis issues, J RHEUMATOL, 27(2), 2000, pp. 544-548
Authors:
MacLean, C
Lassere, M
Strand, V
Citation: C. Maclean et al., Omeract imaging taskforce workshop - Summary discussion, J RHEUMATOL, 27(2), 2000, pp. 552-552
Authors:
Schiff, MH
Strand, V
Oed, C
Loew-Friedrich, I
Citation: Mh. Schiff et al., Leflunomide: Efficacy and safety in clinical trials for the treatment of rheumatoid arthritis, DRUGS TODAY, 36(6), 2000, pp. 383-394
Authors:
Sharp, JT
Strand, V
Leung, H
Hurley, F
LoewFriedrich, I
Citation: Jt. Sharp et al., Treatment with leflunomide slows radiographic progression of rheumatoid arthritis - Results from three randomized controlled trials of leflunomide inpatients with active rheumatoid arthritis (vol 43, pg 495, 2000), ARTH RHEUM, 43(6), 2000, pp. 1345-1345
Authors:
Sharp, JT
Strand, V
Leung, H
Hurley, F
Loew-Friedrich, I
Citation: Jt. Sharp et al., Treatment with leflunomide slows radiographic progression of rheumatoid arthritis - Results from three randomized controlled trials of leflunomide inpatients with active rheumatoid arthritis, ARTH RHEUM, 43(3), 2000, pp. 495-505